ID   OSBL5_HUMAN             Reviewed;         879 AA.
AC   Q9H0X9; A6NDP0; A6NJS8; B4DVB0; Q54A90; Q8N596; Q9BZB0; Q9P1Z4;
DT   11-FEB-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   28-JUN-2023, entry version 175.
DE   RecName: Full=Oxysterol-binding protein-related protein 5;
DE            Short=ORP-5;
DE            Short=OSBP-related protein 5;
DE   AltName: Full=Oxysterol-binding protein homolog 1 {ECO:0000303|PubMed:12504849};
GN   Name=OSBPL5;
GN   Synonyms=KIAA1534, OBPH1 {ECO:0000303|PubMed:12504849}, ORP5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), IMPRINTING, AND TISSUE SPECIFICITY.
RX   PubMed=12504849; DOI=10.1006/geno.2002.7006;
RA   Higashimoto K., Soejima H., Yatsuki H., Joh K., Uchiyama M., Obata Y.,
RA   Ono R., Wang Y., Xin Z., Zhu X., Masuko S., Ishino F., Hatada I., Jinno Y.,
RA   Iwasaka T., Katsuki T., Mukai T.;
RT   "Characterization and imprinting status of OBPH1/Obph1 gene: implications
RT   for an extended imprinting domain in human and mouse.";
RL   Genomics 80:575-584(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=11735225; DOI=10.1006/geno.2001.6663;
RA   Jaworski C.J., Moreira E., Li A., Lee R., Rodriguez I.R.;
RT   "A family of 12 human genes containing oxysterol-binding domains.";
RL   Genomics 78:185-196(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Anniss A.M., Apostolopoulos J., Sparrow R.L.;
RT   "Isolation and characterization of human oxysterol-binding protein-related
RT   protein-5 (ORP-5).";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Small intestine, and Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-61 (ISOFORM 1).
RX   PubMed=11483621;
RA   Lehto M., Laitinen S., Chinetti G., Johansson M., Ehnholm C., Staels B.,
RA   Ikonen E., Olkkonen V.M.;
RT   "The OSBP-related protein family in humans.";
RL   J. Lipid Res. 42:1203-1213(2001).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 30-879 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10819331; DOI=10.1093/dnares/7.2.143;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:143-150(2000).
RN   [11]
RP   FUNCTION.
RX   PubMed=17428193; DOI=10.1042/bj20070176;
RA   Suchanek M., Hynynen R., Wohlfahrt G., Lehto M., Johansson M., Saarinen H.,
RA   Radzikowska A., Thiele C., Olkkonen V.M.;
RT   "The mammalian oxysterol-binding protein-related proteins (ORPs) bind 25-
RT   hydroxycholesterol in an evolutionarily conserved pocket.";
RL   Biochem. J. 405:473-480(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-747, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-747, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   LACK OF IMPRINTING.
RX   PubMed=20644730; DOI=10.1371/journal.pone.0011595;
RA   Frost J.M., Udayashankar R., Moore H.D., Moore G.E.;
RT   "Telomeric NAP1L4 and OSBPL5 of the KCNQ1 cluster, and the DECORIN gene are
RT   not imprinted in human trophoblast stem cells.";
RL   PLoS ONE 5:E11595-E11595(2010).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-747, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=21220512; DOI=10.1083/jcb.201004142;
RA   Du X., Kumar J., Ferguson C., Schulz T.A., Ong Y.S., Hong W., Prinz W.A.,
RA   Parton R.G., Brown A.J., Yang H.;
RT   "A role for oxysterol-binding protein-related protein 5 in endosomal
RT   cholesterol trafficking.";
RL   J. Cell Biol. 192:121-135(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-747, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   FUNCTION.
RX   PubMed=23934110; DOI=10.1038/nature12430;
RA   Maeda K., Anand K., Chiapparino A., Kumar A., Poletto M., Kaksonen M.,
RA   Gavin A.C.;
RT   "Interactome map uncovers phosphatidylserine transport by oxysterol-binding
RT   proteins.";
RL   Nature 501:257-261(2013).
RN   [19]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LEU-389 AND
RP   478-HIS-HIS-479.
RX   PubMed=26206935; DOI=10.1126/science.aab1370;
RA   Chung J., Torta F., Masai K., Lucast L., Czapla H., Tanner L.B.,
RA   Narayanaswamy P., Wenk M.R., Nakatsu F., De Camilli P.;
RT   "PI4P/phosphatidylserine countertransport at ORP5- and ORP8-mediated ER-
RT   plasma membrane contacts.";
RL   Science 349:428-432(2015).
RN   [20]
RP   SUBCELLULAR LOCATION.
RX   PubMed=30220461; DOI=10.1016/j.cell.2018.08.033;
RA   Sandhu J., Li S., Fairall L., Pfisterer S.G., Gurnett J.E., Xiao X.,
RA   Weston T.A., Vashi D., Ferrari A., Orozco J.L., Hartman C.L.,
RA   Strugatsky D., Lee S.D., He C., Hong C., Jiang H., Bentolila L.A.,
RA   Gatta A.T., Levine T.P., Ferng A., Lee R., Ford D.A., Young S.G.,
RA   Ikonen E., Schwabe J.W.R., Tontonoz P.;
RT   "Aster proteins facilitate nonvesicular plasma membrane to ER cholesterol
RT   transport in mammalian cells.";
RL   Cell 175:514-529(2018).
CC   -!- FUNCTION: Lipid transporter involved in lipid countertransport between
CC       the endoplasmic reticulum and the plasma membrane: specifically
CC       exchanges phosphatidylserine with phosphatidylinositol 4-phosphate
CC       (PI4P), delivering phosphatidylserine to the plasma membrane in
CC       exchange for PI4P, which is degraded by the SAC1/SACM1L phosphatase in
CC       the endoplasmic reticulum. Binds phosphatidylserine and PI4P in a
CC       mutually exclusive manner (PubMed:23934110, PubMed:26206935). May
CC       cooperate with NPC1 to mediate the exit of cholesterol from
CC       endosomes/lysosomes (PubMed:21220512). Binds 25-hydroxycholesterol and
CC       cholesterol (PubMed:17428193). {ECO:0000269|PubMed:17428193,
CC       ECO:0000269|PubMed:21220512, ECO:0000269|PubMed:23934110,
CC       ECO:0000269|PubMed:26206935}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:21220512, ECO:0000269|PubMed:26206935}; Single-pass
CC       membrane protein {ECO:0000269|PubMed:21220512}. Note=Localizes to
CC       endoplasmic reticulum-plasma membrane contact sites (EPCS). Localizes
CC       to the cortical endoplasmic reticulum at the EPCS.
CC       {ECO:0000269|PubMed:26206935, ECO:0000269|PubMed:30220461}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9H0X9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H0X9-2; Sequence=VSP_043071;
CC       Name=3;
CC         IsoId=Q9H0X9-3; Sequence=VSP_057408, VSP_057409;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:12504849, ECO:0000269|PubMed:21220512}.
CC   -!- MISCELLANEOUS: According to a report, the gene is imprinted in
CC       placenta, where it is predominantly expressed from the maternal allele
CC       only. Not imprinted in other tissues (PubMed:12504849). According to
CC       another report, it is not imprinted in trophoblast stem cells
CC       (PubMed:20644730). {ECO:0000269|PubMed:12504849,
CC       ECO:0000269|PubMed:20644730}.
CC   -!- SIMILARITY: Belongs to the OSBP family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA96058.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB074006; BAB85686.1; -; mRNA.
DR   EMBL; AF392453; AAL40666.1; -; mRNA.
DR   EMBL; AF410430; AAK98617.1; -; mRNA.
DR   EMBL; AL136918; CAB66852.1; -; mRNA.
DR   EMBL; AK056510; BAG51735.1; -; mRNA.
DR   EMBL; AK301003; BAG62622.1; -; mRNA.
DR   EMBL; AC108448; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC877382; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455307; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455310; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471158; EAX02542.1; -; Genomic_DNA.
DR   EMBL; CH471158; EAX02543.1; -; Genomic_DNA.
DR   EMBL; BC032646; AAH32646.2; -; mRNA.
DR   EMBL; BC039579; AAH39579.1; -; mRNA.
DR   EMBL; AF331964; AAG53417.1; -; mRNA.
DR   EMBL; AB040967; BAA96058.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS31343.1; -. [Q9H0X9-2]
DR   CCDS; CCDS31344.1; -. [Q9H0X9-1]
DR   RefSeq; NP_001137535.1; NM_001144063.1. [Q9H0X9-2]
DR   RefSeq; NP_065947.1; NM_020896.3. [Q9H0X9-1]
DR   RefSeq; NP_663613.1; NM_145638.2. [Q9H0X9-2]
DR   RefSeq; XP_011518175.1; XM_011519873.2. [Q9H0X9-1]
DR   RefSeq; XP_016872652.1; XM_017017163.1. [Q9H0X9-1]
DR   AlphaFoldDB; Q9H0X9; -.
DR   SMR; Q9H0X9; -.
DR   BioGRID; 125380; 62.
DR   DIP; DIP-52332N; -.
DR   IntAct; Q9H0X9; 23.
DR   MINT; Q9H0X9; -.
DR   STRING; 9606.ENSP00000263650; -.
DR   SwissLipids; SLP:000000527; -.
DR   TCDB; 2.D.1.1.1; the pi4p/ps counter transporter (p/p-ct) family.
DR   iPTMnet; Q9H0X9; -.
DR   PhosphoSitePlus; Q9H0X9; -.
DR   SwissPalm; Q9H0X9; -.
DR   BioMuta; OSBPL5; -.
DR   DMDM; 20139173; -.
DR   EPD; Q9H0X9; -.
DR   jPOST; Q9H0X9; -.
DR   MassIVE; Q9H0X9; -.
DR   MaxQB; Q9H0X9; -.
DR   PaxDb; Q9H0X9; -.
DR   PeptideAtlas; Q9H0X9; -.
DR   ProteomicsDB; 5257; -.
DR   ProteomicsDB; 80342; -. [Q9H0X9-1]
DR   ProteomicsDB; 80343; -. [Q9H0X9-2]
DR   Antibodypedia; 23281; 100 antibodies from 24 providers.
DR   DNASU; 114879; -.
DR   Ensembl; ENST00000263650.12; ENSP00000263650.7; ENSG00000021762.20. [Q9H0X9-1]
DR   Ensembl; ENST00000348039.9; ENSP00000302872.8; ENSG00000021762.20. [Q9H0X9-2]
DR   Ensembl; ENST00000389989.7; ENSP00000374639.3; ENSG00000021762.20. [Q9H0X9-2]
DR   Ensembl; ENST00000525498.5; ENSP00000433342.1; ENSG00000021762.20. [Q9H0X9-3]
DR   GeneID; 114879; -.
DR   KEGG; hsa:114879; -.
DR   MANE-Select; ENST00000263650.12; ENSP00000263650.7; NM_020896.4; NP_065947.1.
DR   UCSC; uc001lxk.3; human. [Q9H0X9-1]
DR   UCSC; uc010qxq.2; human.
DR   AGR; HGNC:16392; -.
DR   CTD; 114879; -.
DR   DisGeNET; 114879; -.
DR   GeneCards; OSBPL5; -.
DR   HGNC; HGNC:16392; OSBPL5.
DR   HPA; ENSG00000021762; Low tissue specificity.
DR   MIM; 606733; gene.
DR   neXtProt; NX_Q9H0X9; -.
DR   OpenTargets; ENSG00000021762; -.
DR   PharmGKB; PA32829; -.
DR   VEuPathDB; HostDB:ENSG00000021762; -.
DR   eggNOG; KOG2210; Eukaryota.
DR   GeneTree; ENSGT00940000159535; -.
DR   HOGENOM; CLU_012334_2_1_1; -.
DR   InParanoid; Q9H0X9; -.
DR   OMA; WESAKLW; -.
DR   OrthoDB; 1018068at2759; -.
DR   PhylomeDB; Q9H0X9; -.
DR   TreeFam; TF312807; -.
DR   PathwayCommons; Q9H0X9; -.
DR   Reactome; R-HSA-1482801; Acyl chain remodelling of PS.
DR   SignaLink; Q9H0X9; -.
DR   BioGRID-ORCS; 114879; 11 hits in 1154 CRISPR screens.
DR   ChiTaRS; OSBPL5; human.
DR   GeneWiki; OSBPL5; -.
DR   GenomeRNAi; 114879; -.
DR   Pharos; Q9H0X9; Tbio.
DR   PRO; PR:Q9H0X9; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q9H0X9; protein.
DR   Bgee; ENSG00000021762; Expressed in pancreatic ductal cell and 182 other tissues.
DR   ExpressionAtlas; Q9H0X9; baseline and differential.
DR   Genevisible; Q9H0X9; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0140268; C:endoplasmic reticulum-plasma membrane contact site; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0015485; F:cholesterol binding; IDA:BHF-UCL.
DR   GO; GO:0008142; F:oxysterol binding; NAS:UniProtKB.
DR   GO; GO:0070273; F:phosphatidylinositol-4-phosphate binding; IDA:UniProtKB.
DR   GO; GO:0001786; F:phosphatidylserine binding; IDA:UniProtKB.
DR   GO; GO:0140343; F:phosphatidylserine transfer activity; IDA:GO_Central.
DR   GO; GO:0005548; F:phospholipid transporter activity; TAS:Reactome.
DR   GO; GO:0032934; F:sterol binding; IBA:GO_Central.
DR   GO; GO:0015248; F:sterol transporter activity; IBA:GO_Central.
DR   GO; GO:0008203; P:cholesterol metabolic process; NAS:UniProtKB.
DR   GO; GO:0030301; P:cholesterol transport; NAS:UniProtKB.
DR   GO; GO:0006893; P:Golgi to plasma membrane transport; NAS:UniProtKB.
DR   GO; GO:0036150; P:phosphatidylserine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0015914; P:phospholipid transport; IDA:UniProtKB.
DR   CDD; cd13286; PH_OPR5_ORP8; 1.
DR   Gene3D; 1.10.287.2720; -; 1.
DR   Gene3D; 2.40.160.120; -; 1.
DR   Gene3D; 3.30.70.3490; -; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   InterPro; IPR037239; OSBP_sf.
DR   InterPro; IPR000648; Oxysterol-bd.
DR   InterPro; IPR018494; Oxysterol-bd_CS.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   PANTHER; PTHR10972; OXYSTEROL-BINDING PROTEIN-RELATED; 1.
DR   PANTHER; PTHR10972:SF102; OXYSTEROL-BINDING PROTEIN-RELATED PROTEIN 5; 1.
DR   Pfam; PF01237; Oxysterol_BP; 2.
DR   Pfam; PF00169; PH; 1.
DR   SMART; SM00233; PH; 1.
DR   SUPFAM; SSF144000; Oxysterol-binding protein-like; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   PROSITE; PS01013; OSBP; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Endoplasmic reticulum; Lipid transport;
KW   Lipid-binding; Membrane; Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..879
FT                   /note="Oxysterol-binding protein-related protein 5"
FT                   /id="PRO_0000100373"
FT   TRANSMEM        860..878
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          126..243
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   REGION          1..73
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          254..341
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          742..806
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          93..123
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        299..326
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        766..786
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         384..389
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol
FT                   4-phosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58178"
FT                   /evidence="ECO:0000250|UniProtKB:Q02201"
FT   BINDING         384..389
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-L-serine"
FT                   /ligand_id="ChEBI:CHEBI:57262"
FT                   /evidence="ECO:0000250|UniProtKB:Q02201"
FT   BINDING         446..449
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol
FT                   4-phosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58178"
FT                   /evidence="ECO:0000250|UniProtKB:Q02201"
FT   BINDING         449
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-L-serine"
FT                   /ligand_id="ChEBI:CHEBI:57262"
FT                   /evidence="ECO:0000250|UniProtKB:Q02201"
FT   BINDING         478..479
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol
FT                   4-phosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58178"
FT                   /evidence="ECO:0000250|UniProtKB:Q02201"
FT   BINDING         504
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-L-serine"
FT                   /ligand_id="ChEBI:CHEBI:57262"
FT                   /evidence="ECO:0000250|UniProtKB:Q02201"
FT   BINDING         670
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol
FT                   4-phosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58178"
FT                   /evidence="ECO:0000250|UniProtKB:Q02201"
FT   BINDING         674
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol
FT                   4-phosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58178"
FT                   /evidence="ECO:0000250|UniProtKB:Q02201"
FT   BINDING         678
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol
FT                   4-phosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58178"
FT                   /evidence="ECO:0000250|UniProtKB:Q02201"
FT   MOD_RES         12
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ER64"
FT   MOD_RES         747
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..48
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_057408"
FT   VAR_SEQ         134..201
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043071"
FT   VAR_SEQ         161..201
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_057409"
FT   VARIANT         90
FT                   /note="T -> I (in dbSNP:rs6578323)"
FT                   /id="VAR_060079"
FT   VARIANT         774
FT                   /note="A -> T (in dbSNP:rs2277301)"
FT                   /id="VAR_020414"
FT   MUTAGEN         389
FT                   /note="L->D: Impaired lipid countertransport between the
FT                   endoplasmic reticulum and the plasma membrane."
FT                   /evidence="ECO:0000269|PubMed:26206935"
FT   MUTAGEN         478..479
FT                   /note="HH->AA: Impaired lipid countertransport between the
FT                   endoplasmic reticulum and the plasma membrane."
FT                   /evidence="ECO:0000269|PubMed:26206935"
SQ   SEQUENCE   879 AA;  98616 MW;  7EF06544347CC60A CRC64;
     MKEEAFLRRR FSLCPPSSTP QKVDPRKLTR NLLLSGDNEL YPLSPGKDME PNGPSLPRDE
     GPPTPSSATK VPPAEYRLCN GSDKECVSPT ARVTKKETLK AQKENYRQEK KRATRQLLSA
     LTDPSVVIMA DSLKIRGTLK SWTKLWCVLK PGVLLIYKTP KVGQWVGTVL LHCCELIERP
     SKKDGFCFKL FHPLDQSVWA VKGPKGESVG SITQPLPSSY LIFRAASESD GRCWLDALEL
     ALRCSSLLRL GTCKPGRDGE PGTSPDASPS SLCGLPASAT VHPDQDLFPL NGSSLENDAF
     SDKSERENPE ESDTETQDHS RKTESGSDQS ETPGAPVRRG TTYVEQVQEE LGELGEASQV
     ETVSEENKSL MWTLLKQLRP GMDLSRVVLP TFVLEPRSFL NKLSDYYYHA DLLSRAAVEE
     DAYSRMKLVL RWYLSGFYKK PKGIKKPYNP ILGETFRCCW FHPQTDSRTF YIAEQVSHHP
     PVSAFHVSNR KDGFCISGSI TAKSRFYGNS LSALLDGKAT LTFLNRAEDY TLTMPYAHCK
     GILYGTMTLE LGGKVTIECA KNNFQAQLEF KLKPFFGGST SINQISGKIT SGEEVLASLS
     GHWDRDVFIK EEGSGSSALF WTPSGEVRRQ RLRQHTVPLE EQTELESERL WQHVTRAISK
     GDQHRATQEK FALEEAQRQR ARERQESLMP WKPQLFHLDP ITQEWHYRYE DHSPWDPLKD
     IAQFEQDGIL RTLQQEAVAR QTTFLGSPGP RHERSGPDQR LRKASDQPSG HSQATESSGS
     TPESCPELSD EEQDGDFVPG GESPCPRCRK EARRLQALHE AILSIREAQQ ELHRHLSAML
     SSTARAAQAP TPGLLQSPRS WFLLCVFLAC QLFINHILK
//
